A phase II clinical trial of peptichemio. Clinical screening cooperative group of European Organisation on Research on Treatment of Cancer (E.O.R.T.C).
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D009447:Neuroblastoma / Q000188:drug therapy; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D010440:Peptichemio / Q000627:therapeutic use* / Q000633:toxicity; D012142:Respiratory Tract Neoplasms / Q000188:drug therapy
D009588:Nitrogen Mustard Compounds; D010440:Peptichemio